p marcks Search Results


anti phospho myristoylated alanine rich c kinase substrate marcks  (Novus Biologicals)
90
Novus Biologicals anti phospho myristoylated alanine rich c kinase substrate marcks
Fig. 5. HDL, but not AcLDL, stimulates phosphorylation of the protein kinase C (PKC) substrate myristoylated alanine-rich C- kinase substrate <t>(MARCKS).</t> mSR-BI-overexpressing (ldlA[mSR- BI]) cells, prepared as described in the legend to Fig. 4, were given serum-free Hams F12 medium containing either no additions (lane 1), 0.5 mM PMA, HDL, or AcLDL (each at 50 mg/ml), 5 mM RO31-8220, a 1:1000 dilution of an anti-SR-BI blocking antiserum, or combinations as indicated. Cells were incubated for 3 min, at which time they were rapidly chilled on ice, then washed, lysed, and analyzed by SDS-PAGE and immunoblotting for either phospho- MARCKS or b-actin. The data are representative of multiple experi- ments. For the experiment shown, lanes 9 and 10 were from a different portion of the same gel.
Anti Phospho Myristoylated Alanine Rich C Kinase Substrate Marcks, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti phospho myristoylated alanine rich c kinase substrate marcks/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
anti phospho myristoylated alanine rich c kinase substrate marcks - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
phospho marcks ser159 163 polyclonal antibody  (Proteintech)
93
Proteintech phospho marcks ser159 163 polyclonal antibody
Fig. 5. HDL, but not AcLDL, stimulates phosphorylation of the protein kinase C (PKC) substrate myristoylated alanine-rich C- kinase substrate <t>(MARCKS).</t> mSR-BI-overexpressing (ldlA[mSR- BI]) cells, prepared as described in the legend to Fig. 4, were given serum-free Hams F12 medium containing either no additions (lane 1), 0.5 mM PMA, HDL, or AcLDL (each at 50 mg/ml), 5 mM RO31-8220, a 1:1000 dilution of an anti-SR-BI blocking antiserum, or combinations as indicated. Cells were incubated for 3 min, at which time they were rapidly chilled on ice, then washed, lysed, and analyzed by SDS-PAGE and immunoblotting for either phospho- MARCKS or b-actin. The data are representative of multiple experi- ments. For the experiment shown, lanes 9 and 10 were from a different portion of the same gel.
Phospho Marcks Ser159 163 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho marcks ser159 163 polyclonal antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
phospho marcks ser159 163 polyclonal antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
primary antibodies against p-synapsin i, phospho-myristoylated alanine-rich c kinase substrate (p-marcks)  (Signalway Antibody)
90
Signalway Antibody primary antibodies against p-synapsin i, phospho-myristoylated alanine-rich c kinase substrate (p-marcks)
DOR activation with DADLE regulated <t>p-synapsin</t> I by BDNF-p-ERK pathway after global ischemia. Western blot analysis of BDNF (A), p-ERK1/2 (B), p-synapsin I (C) expression in rat hippocampus on day 3(left) and day 7(right) after global ischemia. ( N = 3 per group) * P < 0.05. ** P < 0.01. *** P < 0.001.
Primary Antibodies Against P Synapsin I, Phospho Myristoylated Alanine Rich C Kinase Substrate (P Marcks), supplied by Signalway Antibody, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against p-synapsin i, phospho-myristoylated alanine-rich c kinase substrate (p-marcks)/product/Signalway Antibody
Average 90 stars, based on 1 article reviews
primary antibodies against p-synapsin i, phospho-myristoylated alanine-rich c kinase substrate (p-marcks) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-p-marcks (ser152/ 156)  (PhosphoSolutions)
90
PhosphoSolutions anti-p-marcks (ser152/ 156)
DOR activation with DADLE regulated <t>p-synapsin</t> I by BDNF-p-ERK pathway after global ischemia. Western blot analysis of BDNF (A), p-ERK1/2 (B), p-synapsin I (C) expression in rat hippocampus on day 3(left) and day 7(right) after global ischemia. ( N = 3 per group) * P < 0.05. ** P < 0.01. *** P < 0.001.
Anti P Marcks (Ser152/ 156), supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-p-marcks (ser152/ 156)/product/PhosphoSolutions
Average 90 stars, based on 1 article reviews
anti-p-marcks (ser152/ 156) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 5. HDL, but not AcLDL, stimulates phosphorylation of the protein kinase C (PKC) substrate myristoylated alanine-rich C- kinase substrate (MARCKS). mSR-BI-overexpressing (ldlA[mSR- BI]) cells, prepared as described in the legend to Fig. 4, were given serum-free Hams F12 medium containing either no additions (lane 1), 0.5 mM PMA, HDL, or AcLDL (each at 50 mg/ml), 5 mM RO31-8220, a 1:1000 dilution of an anti-SR-BI blocking antiserum, or combinations as indicated. Cells were incubated for 3 min, at which time they were rapidly chilled on ice, then washed, lysed, and analyzed by SDS-PAGE and immunoblotting for either phospho- MARCKS or b-actin. The data are representative of multiple experi- ments. For the experiment shown, lanes 9 and 10 were from a different portion of the same gel.

Journal: Journal of Lipid Research

Article Title: Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovary-derived cells by protein kinase signaling pathways

doi: 10.1194/jlr.m600326-jlr200

Figure Lengend Snippet: Fig. 5. HDL, but not AcLDL, stimulates phosphorylation of the protein kinase C (PKC) substrate myristoylated alanine-rich C- kinase substrate (MARCKS). mSR-BI-overexpressing (ldlA[mSR- BI]) cells, prepared as described in the legend to Fig. 4, were given serum-free Hams F12 medium containing either no additions (lane 1), 0.5 mM PMA, HDL, or AcLDL (each at 50 mg/ml), 5 mM RO31-8220, a 1:1000 dilution of an anti-SR-BI blocking antiserum, or combinations as indicated. Cells were incubated for 3 min, at which time they were rapidly chilled on ice, then washed, lysed, and analyzed by SDS-PAGE and immunoblotting for either phospho- MARCKS or b-actin. The data are representative of multiple experi- ments. For the experiment shown, lanes 9 and 10 were from a different portion of the same gel.

Article Snippet: Rabbit anti-SR-BI antibody (NB400-101) and anti-phospho-myristoylated alanine-rich C-kinase substrate (MARCKS) (NB500-140) were from Novus Biologicals, Inc. (distributed by Cedarlane Laboratories Ltd, Hornby, Ontario, Canada).

Techniques: Phospho-proteomics, Blocking Assay, Incubation, SDS Page, Western Blot

DOR activation with DADLE regulated p-synapsin I by BDNF-p-ERK pathway after global ischemia. Western blot analysis of BDNF (A), p-ERK1/2 (B), p-synapsin I (C) expression in rat hippocampus on day 3(left) and day 7(right) after global ischemia. ( N = 3 per group) * P < 0.05. ** P < 0.01. *** P < 0.001.

Journal: Cell Transplantation

Article Title: Delta Opioid Receptor Activation with Delta Opioid Peptide [d-Ala2, d-Leu5] Enkephalin Contributes to Synaptic Improvement in Rat Hippocampus against Global Ischemia

doi: 10.1177/09636897211041585

Figure Lengend Snippet: DOR activation with DADLE regulated p-synapsin I by BDNF-p-ERK pathway after global ischemia. Western blot analysis of BDNF (A), p-ERK1/2 (B), p-synapsin I (C) expression in rat hippocampus on day 3(left) and day 7(right) after global ischemia. ( N = 3 per group) * P < 0.05. ** P < 0.01. *** P < 0.001.

Article Snippet: After blocking with 5% skim milk, the membranes were incubated with primary antibodies against BDNF (1:100, Santa Cruz Biotechnology), p-ERK1/2, PKCα, β-actin, GAPDH (1:1000, Cell Signaling Technology), p-synapsin I, phospho-myristoylated alanine-rich C kinase substrate (p-MARCKS, 1:1000, Signalway Antibody), PKCε, PKCγ (1:1000, Proteintech Group) overnight at 4°.

Techniques: Activation Assay, Western Blot, Expressing